Search for: "APOTEX V MERCK"
Results 41 - 60
of 117
Sorted by Relevance
|
Sort by Date
11 Apr 2014, 11:29 am
See In re Merck & Co., 800 F.2d 1091, 1099 (Fed. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
12 Dec 2008, 8:42 am
See Merck & Co. v. [read post]
6 Jan 2010, 3:32 am
’ (The SPC Blog) India: Reviewing the Indian Patent Regime after 5 years of the introduction of the pharmaceutical product patent regime (Spicy IP) UK: Department of Health proposing generic prescription drugs option (GenericsWeb) US: 7th Circuit: Enforcing contracts between joint owners: Wisconsin Alumni Research Foundation (WARF) v. [read post]
26 Aug 2009, 6:12 am
F. of L. files antitrust suit against Merck, alleging fraudulent procurement of a patent, improper listing of patent in Orange Book (Patent Docs) Singulair (Montelukast) – US: Merck get injunction preventing Teva from selling generic Montelukast: Merck Sharp & Dohme Pharmaceuticals SRL v Teva Pharmaceuticals USA (The IP Factor) (IP Watchdog) (SmartBrief) (SmartBrief) (GenericsWeb) [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca)… [read post]
29 Jun 2010, 6:01 pm
Apotex Inc. et al. [read post]
30 Jun 2010, 5:52 am
Apotex Inc. et al. [read post]
21 Feb 2024, 4:00 am
Novopharm Ltd., [1998] 2 S.C.R. 129, 161 DLR (4th) 1, Apotex Inc. v. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
1 Dec 2014, 12:36 am
Mercks clash over law governing coexistence dealThe Merck v Merck trade mark dispute (real name: Merck KGaA v Merck Sharp & Dohme Corp and others) has already appeared a couple of times on this weblog [see here and here], with the further honour to have a dedicated poll on who between the Germans and the Americans should have right to use that much-contended name. [read post]
29 Mar 2011, 9:19 pm
Merck (Kluwer Patent Blog) Keppra (Levetiracetam) – US: Orange Book patent listing precipitates DJ action to trigger generic Keppra XR 180-day exclusivity forfeiture: Par Pharmaceutical v UCB et al (FDA Law Blog) (Patent Docs) Naropin (Ropivacaine) – US: Judge O’Malley in dissent: Patent assignments should be a matter of state law: Abraxis BioScience v. [read post]
31 Jul 2015, 4:30 am
A simple song with a complex copyright history and lawsuit http://t.co/89sehViGAE -> New survey says cybersecurity worries among execs have risen sharply, promotes more info sharing http://t.co/B9Zprv5igJ -> David Cameron warns porn websites to block under-18s or face legal curbs http://t.co/ppjHbJRrd4 -> RIAA and Friends Accuse CNET of Hosting 'Pirate' Software http://t.co/XFxw6BQ4y2 -> Chinese Hackers Reportedly Hit United Airlines http://t.co/NCJhK51L7Q -> Federal Court… [read post]
19 Jan 2010, 12:00 am
(Merck and Co. [read post]
9 Aug 2015, 4:30 am
http://t.co/qIisfUtxY5 -> District Court Rejects Plaintiffs' Narrow Construction of the Term “User” under DMCA https://t.co/t04II91AdL -> The Copyright License As a Property Right http://t.co/5OSSPV9wwo -> Lin to decision in Minden Pictures, Inc. v. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
12 Apr 2014, 6:39 am
Cir. 2007);Pfizer, Inc. v. [read post]
5 Nov 2013, 4:00 am
Merck & Co. [read post]
